SMS Pharmaceuticals: CARE Ratings upgrades short-term credit, revises long-term outlook to positive

SMS Pharmaceuticals Limited today announced that CARE Ratings Limited has reaffirmed and upgraded its credit ratings for the company's bank facilities, as communicated in a letter dated December 03, 2025. The long-term bank facilities, totaling INR 350.87 crore, saw their rating reaffirmed as 'CARE A' with the outlook revised from Stable to Positive. This indicates a stronger position regarding long-term obligations.

The short-term bank facilities, amounting to INR 52.83 crore, received an upgrade from 'CARE A2+' to 'CARE A1'. This upgrade signifies an improved assessment of the company's ability to meet its short-term financial commitments. The revised ratings are based on a review of the company's operational and financial performance for FY25 (audited) and H1FY26 (abridged).

The total facilities rated amount to INR 403.70 crore, encompassing various long-term and short-term fund-based and non-fund-based limits from multiple banks, including the State Bank of India, IDBI Bank Ltd., Export Import Bank of India, and RBL Bank Limited.